NEW YORK CITY

IBTimes Logo

Missing New York cobra bites Twitter

A 20-inch pencil-thin Egyptian cobra, which escaped from the Bronx Zoo in New York last week, is giving Charlie Sheen and Lady Gaga tough competition on Twitter. A twitter account created by an anonymous user under the name BronxZoosCobra had more than 120,000 followers by early Wednesday.
More news
Traders work on the floor of the New York Stock Exchange

US Earnings Watch For March 23 (GIS, PAYX, RHT, FUL, SAI, SCS, TXI, WATG, OMN)

The top U.S. companies that are reporting earnings before the market opens on March 23 are: General Mills, Texas Industries, and Wonder Auto Technology. The top U.S. companies that are reporting earnings after the market close on March 23 are: Paychex, Red Hat, SAIC, Steelcase, HB Fuller, and OMNOVA Solutions.
Celera, Quest Diagnostics Merger

Celera Stock Hits New High On Quest Diagnostics Merger

Shares of Celera Corp. (NASDAQ: CRA) touched a new 52-week high of $8.42 on Friday, as it agreed to be acquired by Quest Diagnostics Inc. (NYSE: DGX) for $8 a share or about $344 million in cash, net of $327 million in acquired cash and short-term investments.
IBTimes Logo

Nasdaq plans for rival NYSE bid hit snag: report

Nasdaq OMX Group Inc's plans to launch a rival bid for NYSE Euronext faces hurdles as differences with potential partner IntercontinentalExchange Inc persist, the Wall Street Journal reported on its website on Thursday.
IBTimes Logo

Nasdaq bid for NYSE could come this week: report

Nasdaq OMX Group Inc is preparing an offer for NYSE Euronext and the bid could come as early as this week, the Wall Street Journal reported on Monday, citing people familiar with the matter.
IBTimes Logo

Deep probe expected for D.Boerse-NYSE merger

EU regulators are likely to take a long, hard look at Deutsche Boerse's planned takeover of NYSE Euronext, the EU's antitrust chief said, while a top NYSE executive said talks with authorities globally are so far going well.
A sign marks the headquarters of Genzyme in Cambridge

Genzyme Shares Hit New High Again

Genzyme Corp. (NASDAQ: GENZ) said Monday that its board has unanimously recommended to its shareholders to accept the latest sweetened offer from French drug giant Sanofi-Aventis SA (NYSE: SNY) and to tender their shares into the revised offer. The shares of Genzyme touched a new 52-week high of $76.09 on Wednesday.
IBTimes Logo

NYSE faces tough fight with CME, CFO says

NYSE Euronext's planned assault this month on CME Group Inc's flagship U.S. rate futures franchise will be tough going because traders value liquidity, CME Chief Financial Officer Jamie Parisi said on Wednesday.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.